StonvexLoading…
StonvexStonvexStonvexCore line items from INGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $295.30M | $278.76M | $251.61M | $320.55M |
Operating Income | $-30.21M | $-42.52M | $-109.39M | $-85.24M |
Net Income | $-22.75M | $-35.89M | $-102.45M | $-83.77M |
EPS (Diluted) | $-0.86 | $-1.52 | $-4.42 | $-3.67 |
Total Assets | $298.63M | $296.19M | $326.19M | $405.04M |
Total Liabilities | $106.39M | $122.33M | $121.38M | $107.64M |
Cash & Equivalents | $103.73M | $113.80M | $125.49M | $187.01M |
Free Cash Flow OCF − CapEx | $-13.74M | $2.55M | $-8.45M | $-40.87M |
Shares Outstanding | 27.23M | 23.90M | 23.32M | 22.94M |